INTRODUCTION
According to statistics from the Ministry of Health and Welfare, breast cancer is the second most common cancer among Korean women following thyroid cancer. The incidence of breast cancer increased steadily, reaching 5,744 per 100,000 in 1999, but tripled to 18,381 in 2014. In addition, the 5-year relative survival rate of breast cancer patients in the last 5 years (2010-2014) is 92%, showing a high survival rate along with thyroid cancer and prostate cancer (1) . Breast magnetic resonance imaging (MRI) combined with mammography has been reported to be 90% to 100% sensitive in detecting breast cancer. Its usefulness has been reported not only in high-risk screening but also in pre-operative examination, evaluation of neoadjuvant chemotherapy response, and post-operative screening (2) (3) (4) (5) . The use of breast MRI has been rapidly growing in Korea for the last 10 years. However, there are several problems associated with breast MRI. There are recommendations for breast MRI from the American Cancer Society (ACS) (6), the medical environment is different in Korea. Thus, it is necessary to know the types of indications that are actually used. Since there is no standard imaging protocol, hospitals use different planes and sequences, making it difficult to read images taken by other institutions. Furthermore, unlike the United States, which has a breast MRI accreditation program, there is no regulation in Korea, and image quality is not well managed. Regarding the standardization of imaging interpretation, it seems that the Breast Imaging Reporting and Data System (BI-RADS) (7) from the American College of Radiology (ACR) is often used for interpretation; it is not clear how many hospitals actually use it. Some hospitals that perform breast MRI do not perform the MRI-guided biopsy for lesions that are visible only on MRI. The purpose of our study was to report on the current practices in breast MRI in Korea. The questionnaire included the characteristics of the hospitals in which the breast MRI was performed, type of practices, indications, techniques and protocols used, type of interpretation, clinician's understanding of breast MRI, and availability of breast MRI intervention. The information from this survey would provide the basis for the development of Korean breast MRI practice guidelines.
MATERIALS AND METHODS
From October 2015 to January 2016, we invited the 68 members of the Korean Society of Breast Imaging (KSBI) working in breast MR-available hospitals to participate in a survey regarding how they performed and interpreted breast MR. We asked one member from each hospital to respond to the survey. The survey was conducted by email. Two follow-up emails were sent to non-respondents. A total of 22 surveys from 22 hospitals were analyzed. The respondents returned the survey within 3 months from the first contact. The questionnaire used in this study was developed with reference to the questionnaire developed in the United States (8) by collaboration of breast radiologists who were familiar with the recent trends in breast MRI. This survey consisted of 28 questions divided into 5 categories (Appendix). It covered baseline characteristics of respondents, breast MRI indication, protocol and technique, interpretation, and breast MRI-guided intervention. The results of the survey were evaluated by all of the authors.
RESULTS

Baseline Characteristics of Respondents
Most respondents were below 40 years of age (95.5%), and all were female. The type of hospital in this survey included 21 university hospitals and 1 secondary hospital. Thirteen hospitals (59%) performed more than 300 breast MRI exams per year, of which 5 hospitals (23%) performed more than 1200 exams a year. Table 1 shows the detailed baseline characteristics of the respondents.
Breast MR Indications
For the indications for diagnostic breast MRI, the results are shown in Figure 1 . All respondents perform diagnostic MRI in their hospitals. The most common indications were to follow up for response to chemotherapy (21, 95.5%) and pre-operative evaluation (21, 95.5%). In 14 hospitals, pre-operative MRI is performed on breast cancer patients regardless of operation method. Four hospitals perform MRI only for breast cancer patients who are scheduled for breast conservation surgery. In contrast, 2 hospitals perform MRI only for patients who undergo mastectomy. One hospital performs pre-operative MRI for patients who have dense breasts.
Out of 22 hospitals, 17 perform screening breast MRI. Figure 2 shows the responses from these 17 hospitals. The most common indication for screening was patients with interstitial injection, followed by patients with a history of breast cancer, patients who ask for MRI screening, and patients with implants. The proportion of MRI screening for patients with BRCA mutation and those with a history of high-risk lesions are lower compared to that in the United States. Figure 3 shows the responses about clinicians' MRI prescriptions. Respondents said that most clinicians prescribed breast MRI appropriately.
Breast MRI Protocols and Technique
In 22 hospitals, 31 MRIs were used for breast examinations; 17 machines were 3-T scanners, and the remaining 14 machines were 1.5-T scanners. Contrast-enhanced breast MRI is available in all of the hospitals. Non-contrast breast MRI is not performed in 3 hospitals. Gadovist (Bayer Schering Pharma AG, Berlin, Germany), Dotarem (Guerbet, Paris, France), Prohance (Bracco, Milan, Italy), Uniray (Dongkook Pharm, Seoul, Korea), and Multihance (Bracco, Milan, Italy) were used for contrast-enhanced breast MRI. Machine injection is preferred over manual injection. MRI examinations in all except one hospital do not take menstrual cycles into account, even if they are for screening. Five hospitals record menstrual cycles for MRI interpretation. For breast MRI dynamic protocols, all respondents performed bilateral breast MRI. Fifteen (68.2%) hospitals performed dynamic scan in the axial plane, five (22.7%) in the sagittal plane, and two (9.1%) in the mixed plane. For the dynamic series, 18 hospitals preferred using fat saturation and 1 preferred non-fat saturation, while the other 3 used both of them. All hospitals performed T2 weighted image (T2WI), 14 (64.6%) with fat saturation and 8 (36.4%) without fat saturation. Half of the hospitals used pre-contrast non-fat saturated images to evaluate fat-containing lesions and subcutaneous fat. T1 weighted (T1WI) (n = 7, 40.9%) and T2WI (n = 6, 36.4%) images were used for this non-fat saturated sequence. Two hospitals did non-fat saturated for both T1WI and T2WI images. Out of 22 hospitals, 19 performed reformatted orthogonal plane images with dynamic series. Maximum intensity projection was the most commonly used reconstruction. In addition, diffusion weighted images were performed in 18 hospitals and MR spectroscopy was performed in 1 hospital. 
Breast MRI Interpretation
Full-time breast radiologists supervised the performance and interpretation of breast MRI in 19 of 22 (86.4%) hospitals. All hospitals used BI-RADS for MRI interpretation. Regarding the use of computer-aided diagnosis (CAD), "sometimes or always" was the answer in 13 (59.1%) hospitals and "no" was the answer in 9 (40.9%) hospitals. Out of 22, 14 practices (63.6%) "never or rarely" interpreted breast MRI without correlating mammography or ultrasound and the other 8 practices "sometimes or frequently" did. The majority of respondents (16/21, 76.2%) interpreted breast MRI performed at an outside facility, but there were several hospitals that never interpreted MRI (5/21, 23.8%) that was performed in another hospital. Out of 22, 17 (77.3%) hospitals did not audit a breast MR practice.
MRI Guided Interventions
Out of 21 hospitals, 19 performed "second-look" ultrasound for suspicious breast MRI findings and 2 "rarely" did. Of the hospitals that perform breast MRI examinations, 15 of 22 (68.2%) did not perform MRI-guided interventional procedures. Six hospitals performed MRI-guided biopsy based only on their images and one hospital did biopsy not only based on their images but also based on images taken in other institutions. From 12G to 8G vacuumassisted devices used for MRI guided biopsy and none of the respondents used core gun for MRI-guided biopsy.
DISCUSSION
According to the statistical data provided by the Health Insurance Review and Assessment Service in Korea, breast MRI increased more than threefold from 13,692 cases in 2010 to 40,286 cases in 2016 (9) . Although breast MRI examinations performed at primary hospitals or private clinics continue to increase, the majority (97.9%) of the examinations were performed in tertiary hospitals or secondary hospitals until 2016. There is a possibility that the use of breast MRI will continue to increase due to an increase in breast MRI-available centers, an increase in the prevalence of breast cancer, and the attention of people and media.
From this survey, 3 common indications for diagnostic MRI are evaluation of chemotherapy response, preoperative evaluation, and workup for cancer of unknown primary origin. These tests are for patients with confirmed cancer. Inconclusive findings in conventional imaging, which is one of the indications for diagnostic MRI in the United States and Europe, were only performed in some hospitals in Korea. This is probably because the threshold for the expense of an MRI examination is relatively low in breast cancer patients because Korean health insurance supports the cost of breast MRI by the special law, Cancer Patient Registry. Three major conditions for the use of breast MRI screening are interstitial injection, personal history of breast cancer, and patients who ask for breast MR screening. According to the ACS, breast MRI screening is recommended for women who have an approximately 20-25% or greater lifetime risk, BRCA mutation, and untested first-degree relative of BRCA carrier based on evidence. Furthermore, the ACS panel recommended against MRI screening for patients with a personal history of breast cancer who have an estimated absolute lifetime risk of 10% (6) . In Korea, however, screening breast MR is more active in cancer patients because of insurance coverage for the 5 years after diagnosis. High-risk women, such as women with BRCA mutations, who need MRI screening, are not supported by insurance. It is necessary to expand insurance coverage for high-risk groups.
In this survey, 3-T scanners are more frequently used for breast MRI than 1.5-T scanner because almost all respondents worked in a tertiary hospital. Bilateral axial plane where it is easy to compare background parenchymal enhancement, is preferred for dynamic image. For contrastenhanced breast MRI, dynamic image and T2WI are included in all hospitals. However, there are various preferences for acquisition direction or fat saturation images in each hospital. In addition, there are various additional images for each hospital.
Breast MRI results are likely to be interpreted by specialized personnel, and about half of which use CAD. More than one-third of hospitals sometimes or frequently interpret breast MRI without correlating conventional images. Because there is no standardized protocol, breast MRI taken at another institution is difficult to read, but most of the hospitals read outside exams for the clinicians' or patients' needs. To reduce unnecessary repetitive examinations, outside hospital MRI interpretation is essential but a standardized protocol would reduce the error of reading from the unfamiliar MR protocols.
In this questionnaire, 68.2% of the respondents said that they did not perform MRI-guided biopsy even though they were referral hospitals. MRI is a very sensitive test and because of the high rate of cancers that are not detected in other modalities such as ultrasound or mammography (10) (11) (12) , it is not enough to perform a second look ultrasound or mammography correlation. MRI-guided biopsy is necessary. If MRI-guided biopsy cannot be performed in the hospital, there should be a system that can create a referral arrangement with a cooperating facility. In Korea, this system is insufficient. The ACR guideline also states that "facilities performing breast MRI should have the capacity to perform mammographic correlation, directed breast ultrasound, and MRI-guided intervention, or create a referral arrangement with a cooperating facility that could provide these services" (13) . Additionally, only 1 of the 7 hospitals providing MRI-guided biopsy performs a biopsy on the basis of an outside image, and the remaining 6 hospitals perform a biopsy after re-imaging. Repeated exams waste medical resources and increase costs, so image standardization is required.
This study has several limitations. First, only 36.8% of those surveyed responded. There is a possibility of selection bias because this study included only those who voluntarily answered. In addition, all respondents worked in secondary or tertiary hospitals and did not reflect the situation in private clinics. Second, the survey was also made only for KSBI members. The practices of other doctors including breast surgeons who have big private breast clinics were not reflected, and hence it is difficult to represent current breast imaging practices.
Despite these limitations, this study could be important in providing information on the current practices of experts regarding their screening or diagnostic MRI indications and protocols. In addition, this study could provide the basic data for the development of Korean breast MRI guidelines and quality control goals. This study will help create reasonable guidelines for Korean medical environments by providing information on current practices of hospitals that perform breast MRI. The results of this study may also be helpful to hospitals that are currently performing or 
